Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tackling lasting grief: new therapy trial aims to ease emotional pain

NCT ID NCT07207512

Symptom relief Sponsor: Universidad Pontificia Comillas Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 03, 2026 · Updated 4 times

Summary

This study tests whether Emotion-Focused Therapy (EFT) can reduce symptoms of Prolonged Grief Disorder in adults who have lost a loved one. 128 participants will be randomly assigned to either 8-10 weekly therapy sessions or a self-help program. Researchers will measure grief, anxiety, depression, and overall distress over 12 months to see if EFT offers a better way to cope.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Emotion-Focused Therapy (EFT) for grief
What this could lead to
If it works, this could offer a new, emotion-focused treatment option for people with prolonged grief disorder who don't benefit from standard therapies.
What could go wrong
This is a relatively small early-stage trial (128 people) comparing therapy to self-help, not a proven treatment. Results may not apply to everyone, and the self-help group may show less improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 128 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Sep 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (≥18 years). * Undergoing a grief process (including perinatal grief). * Meeting ICD-11 diagnostic criteria for Prolonged Grief Disorder, assessed with the Traumatic Grief Inventory - Clinician Administered (TGI-CA); death occurred six months or more prior to assessment; PG-13-R score ≥30. * Provision of informed consent. * Stable psychopharmacological medication for at least six weeks prior to therapy onset, with physician approval to maintain stability during the intervention. Exclusion Criteria: * Concurrent psychological treatment * Bereavement occurring less than six months prior to the loss * Substance abuse * Eating disorder * Psychosis; * Organic brain syndrome * Suicide risk * Risk of harm to others.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prolonged grief disorder (PGD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Prolonged Grief Disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prolonged grief disorder (PGD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Unidad Clínica de Psicología de la Universidad Pontificia Comillas (UNINPSI)

    RECRUITING

    Madrid, Madrid, 28036, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.